{"filing":{"accession_number":"0001193125-26-368296","cik":"0001750149","ticker":"IKT","company_name":"Inhibikase Therapeutics, Inc.","form":"8-K","filing_date":"2026-08-26","report_date":"2026-08-21","primary_document":"d904831d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1750149/000119312526368296/d904831d8k.htm"},"events":[{"id":29735,"run_id":27241,"accession_number":"0001193125-26-368296","anchor_item_number":"4.01","event_type":"auditor_change","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"The filing discloses the dismissal of CohnReznick LLP as the Company's independent registered public accounting firm effective August 21, 2026, and the simultaneous appointment of Deloitte \u0026 Touche LLP as the new auditor. This is a classic auditor change under Item 4.01, which is material to investors as it affects the registrant's financial reporting oversight and audit independence.","company_name":"Inhibikase Therapeutics, Inc.","ticker":"IKT","filing_date":"2026-08-26","form":"8-K","submitted_at":null,"items":[{"id":32116,"accession_number":"0001193125-26-368296","item_number":"4.01","item_title":null,"event_type":"auditor_change","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"The filing discloses the dismissal of CohnReznick LLP as the Company's independent registered public accounting firm effective August 21, 2026, and the simultaneous appointment of Deloitte \u0026 Touche LLP as the new auditor. This is a classic auditor change under Item 4.01, which is material to investors as it affects the registrant's financial reporting oversight and audit independence.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-26T20:08:53.182004+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":32116,"accession_number":"0001193125-26-368296","item_number":"4.01","item_title":null,"event_type":"auditor_change","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"The filing discloses the dismissal of CohnReznick LLP as the Company's independent registered public accounting firm effective August 21, 2026, and the simultaneous appointment of Deloitte \u0026 Touche LLP as the new auditor. This is a classic auditor change under Item 4.01, which is material to investors as it affects the registrant's financial reporting oversight and audit independence.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-26T20:08:53.182004+00:00","company_name":"Inhibikase Therapeutics, Inc.","ticker":"IKT","filing_date":"2026-08-26"}]}